doc.ai
Palo Alto
About doc.ai
doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building. The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $43.3M
- Funding stage: M&A
- Last round: Seed (Oct 2019)
- Website: doc.ai
- Phone: (650) 521-0380
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Health Care, Machine Learning, Medical
Social Profiles
Canonical: https://fsome.com/organization/doc-ai-63380 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.